🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy

Recruitingn/aAges 18 Years - anyAllSoochow University
NCT06882577 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Written informed consent by patient 2. Age ≥ 18 years 3. Acute ischemic stroke (with matching brain lesion on MR imaging) 4. Enrolment within 24 h after onset of stroke-related symptoms. Exclusion Criteria: 1. Pregnancy and / or breast-feeding. 2. Participation in an interventional study. 3. Patients refuse to participate in the research.
💊

What it tests

  • observational only- no intervention
📍

Where

1 site
The first affiliated hospital of soochow university
Suzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy